Interventional low‐dose azithromycin attenuates cigarette smoke‐induced emphysema and lung inflammation in mice
Abstract Cigarette smoke (CS)‐induced emphysema is an important contributor to chronic obstructive pulmonary disease (COPD). We have shown the efficacy of azithromycin in reducing airway inflammation in COPD and in reducing exacerbations in severe asthma; however, the effects of long‐term azithromyc...
Main Authors: | Matthew G. Macowan, Hong Liu, Marianne D. Keller, Miranda Ween, Rhys Hamon, Hai B. Tran, Sandra Hodge |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-07-01
|
Series: | Physiological Reports |
Subjects: | |
Online Access: | https://doi.org/10.14814/phy2.14419 |
Similar Items
-
Comparison between cigarette smoke-induced emphysema and cigarette smoke extract-induced emphysema
by: Zhi-Hui He, et al.
Published: (2015-03-01) -
Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPD
by: Kristoffer Ostridge, et al.
Published: (2018-02-01) -
Emphysema distribution and annual changes in pulmonary function in male patients with chronic obstructive pulmonary disease
by: Tanabe Naoya, et al.
Published: (2012-04-01) -
Two CHRN susceptibility variants for COPD are genetic determinants of emphysema and chest computed tomography manifestations in Chinese patients
by: Zhao Z, et al.
Published: (2017-05-01) -
Smoking history and emphysema in asthma–COPD overlap
by: Kurashima K, et al.
Published: (2017-12-01)